Lin BioScience, Inc. engages in the development of drugs. It offers medicines for acute leukemia, solid tumors, type 2 diabetes, glioblastoma, and stargardt disease. The company was founded by Yue Hsin Lin on May 12, 2016 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company